Therapeutic options for patients with invasive bladder cancer: the Stanford experience.
Freiha
F S
FS
Department of Surgery, Stanford University Medical Center, Calif. 94305.
D002295:Carcinoma, Transitional Cell / Q000628:therapy*; D003131:Combined Modality Therapy; D006801:Humans; D001749:Urinary Bladder Neoplasms / Q000628:therapy*